Tattoos have exploded in popularity among Americans in recent years, which helps explain why recent research suggesting an association between being tattooed and a higher risk of lymphoma has drawn a lot of attention.
In a 2023 survey, a third of U.S. adults said they have at least one tattoo, the Pew Research Center reports – 11% with one; 22% with more than one. Among women, more than half between ages 18 and 49 have been inked. Those numbers are up from 21% with one or more tattoos in 2012 and 16% in 2003, according to previous surveys.
Millions of people have been tattooed with no known issues beyond the occasional case of next-day buyer’s remorse. However, various health concerns have been raised over the years about tattoos, including the risk of allergic skin reactions to tattoo ink, possible infections from contaminated inks, and the rare chance of skin irritation at the tattoo site when undergoing a magnetic resonance imaging (MRI) exam.
Also, tattoo inks contain various chemicals and metals, some of which can pose toxicological risks under certain conditions, research shows. It’s also known that particles of tattoo ink can migrate from the skin and accumulate in the lymph nodes.
And now, a pair of studies report associations between having tattoos and certain cancers, particularly lymphoma, a cancer that starts in immune-system cells called lymphocytes.
A recent study by Danish researchers, published in BMC Public Health, drew on information from the Danish Twin Tattoo Cohort, a database of more than 5,900 twins, along with Danish cancer records to compare cancer prevalence among people with tattoos versus those without. “Our study suggests an increased hazard of lymphoma and skin cancers among tattooed individuals,” the researchers said.
That study followed 2024 research out of Sweden, published in eClinicalMedicine, that drew on that nation’s cancer registry along with survey results. It reported that lymphoma was found to be 21% more common among tattooed people. (The American Cancer Society projects 89,070 lymphoma diagnoses in the United States in 2025, which is about 0.026% of the total population.)
The two studies did not investigate whether getting tattooed was directly the cause of any increased cancer prevalence or whether that was due to other factors. Nevertheless, both studies generated news headlines and social media posts around the world, along with some pushback.
To help us understand this new research, we turned to Steven Bair, MD, assistant professor in the University of Colorado Department of Medicine’s Division of Hematology with extensive experience in treating various types of lymphoma, particularly B-cell lymphomas, which account for about 85% of all lymphomas. His research specialty is using “big data” to find ways to improve outcomes in patients with lymphoma. (Bair was not involved in either of these recent studies.)